Nuclear Medicine Market to Reach $21.01 Billion by 2030, Driven by Growth in Molecular Imaging and Theranostics

The Nuclear Medicine Market is projected to grow to $21.01 billion by 2030 as demand for molecular imaging and theranostics accelerates. According to MarketsandMarkets™, the market is expected to rise from $10.41 billion in 2025 to $21.01 billion by 2030, for a 15.1% CAGR. Growth is tied to new PET and SPECT tracers, targeted radionuclide therapies, and improvements in imaging systems aimed at enhancing diagnostic accuracy and therapeutic outcomes. Automation in radiopharmacy processes and better isotope production and supply chains are also supporting broader access worldwide. In 2024, the diagnostic segment led the market, while hospitals are forecast to register the fastest growth due to increased investments in imaging infrastructure and integration of in-house radiopharmacy. North America is expected to dominate throughout the forecast period, supported by established radiopharmaceutical ecosystems and healthcare capacity.